Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
5
×
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
5
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drug prices
pfizer
president trump
abbvie
alexion pharmaceuticals
alzheimer's disease
astrazeneca
biogen
bristol-myers squibb
cancer
cancer immunotherapy
department of health and human services
What
drug
5
×
prices
5
×
lower
plan
alzheimer’s
awaited
bio
details
house
long
pharmaceutical
prescription
roundup
afternoon
anathema
annual
anticipated
assessed
attention
away
biotech
blueprint
bringing
ceos
communities
companies
conference
cost
cut
dc
democrat
different
drugs
elements
esmo
europe
executives
fail
gathered
gene
Language
unset
Current search:
drug
×
biotech
×
" detroit blog main "
×
" san francisco top stories "
×
prices
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details